Table of Contents
Chapter 1. Global Endometriosis Market Executive Summary
1.1. Global Endometriosis Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Treatment
1.3.3. By Route of Administration
1.3.4. By End Users
1.3.5. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Endometriosis Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Endometriosis Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Endometriosis
3.1.2. Increased Awareness and Demand for Better Treatment Options
3.2. Market Challenges
3.2.1. Lack of Non-invasive Diagnostic Tests
3.2.2. High Costs of Treatment
3.3. Market Opportunities
3.3.1. Growth in Biopharmaceutical Innovation Hubs
3.3.2. Expansion of End-Use Industries
Chapter 4. Global Endometriosis Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Endometriosis Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Endometriosis Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Superficial Peritoneal Lesion
5.2.2. Endometrioma
5.2.3. Deeply Infiltrating Endometriosis
5.2.4. Others
Chapter 6. Global Endometriosis Market Size & Forecasts by Treatment 2022-2032
6.1. Segment Dashboard
6.2. Global Endometriosis Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Pain Medication
6.2.2. Hormone Birth Control
6.2.3. Gonadotropin-releasing Hormone (GnRH) Analogues
6.2.4. Aromatase Inhibitors
6.2.5. Others
Chapter 7. Global Endometriosis Market Size & Forecasts by Route of Administration 2022-2032
7.1. Segment Dashboard
7.2. Global Endometriosis Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Parenteral
7.2.3. Others
Chapter 8. Global Endometriosis Market Size & Forecasts by End-Users 2022-2032
8.1. Segment Dashboard
8.2. Global Endometriosis Market: End-Users Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Homecare
8.2.3. Speciality Centres
8.2.4. Others
Chapter 9. Global Endometriosis Market Size & Forecasts by Distribution Channel 2022-2032
9.1. Segment Dashboard
9.2. Global Endometriosis Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Hospital Pharmacy
9.2.2. Online Pharmacy
9.2.3. Retail Pharmacy
Chapter 10. Global Endometriosis Market Size & Forecasts by Region 2022-2032
10.1. North America Endometriosis Market
10.1.1. U.S. Endometriosis Market
10.1.1.1. Type breakdown size & forecasts, 2022-2032
10.1.1.2. Treatment breakdown size & forecasts, 2022-2032
10.1.2. Canada Endometriosis Market
10.2. Europe Endometriosis Market
10.2.1. U.K. Endometriosis Market
10.2.2. Germany Endometriosis Market
10.2.3. France Endometriosis Market
10.2.4. Spain Endometriosis Market
10.2.5. Italy Endometriosis Market
10.2.6. Rest of Europe Endometriosis Market
10.3. Asia-Pacific Endometriosis Market
10.3.1. China Endometriosis Market
10.3.2. India Endometriosis Market
10.3.3. Japan Endometriosis Market
10.3.4. Australia Endometriosis Market
10.3.5. South Korea Endometriosis Market
10.3.6. Rest of Asia Pacific Endometriosis Market
10.4. Latin America Endometriosis Market
10.4.1. Brazil Endometriosis Market
10.4.2. Mexico Endometriosis Market
10.4.3. Rest of Latin America Endometriosis Market
10.5. Middle East & Africa Endometriosis Market
10.5.1. Saudi Arabia Endometriosis Market
10.5.2. South Africa Endometriosis Market
10.5.3. Rest of Middle East & Africa Endometriosis Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Pfizer Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Johnson & Johnson Private Limited
11.3.3. Teva Pharmaceutical Industries Ltd.
11.3.4. Sanofi
11.3.5. Merck & Co., Inc.
11.3.6. Boehringer Ingelheim International GmbH
11.3.7. Novartis AG
11.3.8. GlaxoSmithKline plc
11.3.9. Bayer AG
11.3.10. AstraZeneca
11.3.11. Eli Lilly and Company
11.3.12. Astellas Pharma Inc.
11.3.13. Bristol-Myers Squibb Company
11.3.14. Almirall, S.A
11.3.15. Cadila Pharmaceuticals
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes